表紙
市場調查報告書

生物外科的全球市場:2019年∼2025年

Global Biosurgery Market (2019-2025)

出版商 KBV Research 商品編碼 921118
出版日期 內容資訊 英文 222 Pages
訂單完成後即時交付
價格
生物外科的全球市場:2019年∼2025年 Global Biosurgery Market (2019-2025)
出版日期: 2019年12月31日內容資訊: 英文 222 Pages
簡介

全球生物外科市場規模至2025年預計將達到169億美元,在預測期間內預計將以6.8%的年複合成長率的速度成長。生物外科,由於合成物質與生物製品的恰當組合,提供了再生治癒新的可能性。來自主要的生命科學企業的集中性研究產生的多用途產品的引進,打開了生物外科市場上盈利高的展望的未來。醫療相關人員,開發新的生醫材料,積極地著重提高市場的新前景。

本報告提供全球生物外科市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 市場範圍和調查方法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 競爭分析 - 世界

  • KBV基數矩陣
  • 最近的產業整體策略性開發
  • 主要的成功策略

第4章 全球生物外科市場:各適應症

  • 一般外科
  • 整形外科
  • 神經外科
  • 心血管外科
  • 其他適應

第5章 全球生物外科市場:各產品

  • 外科用密封膠
  • 軟組織附著
  • 黏合障礙
  • 止血劑
  • 骨移植片替代
  • 其他

第6章 全球生物外科市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第7章 企業簡介

  • Baxter International, Inc.
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Integra LifeSciences Holdings Corporation
  • CSL Limited
目錄

The Global Biosurgery Market size is expected to reach $16.9 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.

Biological products like fibrin can be used to reduce adhesions post-surgery. General surgery involves surgeries of the esophagus, abdomen, stomach, colon, small bowel, liver, gallbladder and bile ducts, pancreas, and thyroid gland. It also includes surgeries like rhytidectomy, gynecological surgeries, and reconstructive, urological, as well as hernia-repair surgeries. Biological products can be used in several applications in orthopedic surgeries. Postoperative blood loss is a crucial issue that leads to a high rate of mortality. In order to prevent excessive blood loss at the time of hip and knee arthroplasty, hemostatic agents like intravenous tranexamic acid are used.

Advancements in surgeries and product launches assist surgeons in performing surgeries efficiently. This can prove to be a catalyst in accelerating market growth over the forecast period. The rise of chronic disorders and acute diseases across the geriatric population are coupled with an increased demand for improved surgical care for patients of all ages. This is further augmenting market growth. Furthermore, advancements in marketing strategies of medical devices and the accelerated medical tourism across developing economies are initiating opportunities for manufacturers to magnify their customer base.

Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Acquisition and Mergers. Based on the Analysis presented in the Cardinal matrix, Johnson and Johnson and Pfizer, Inc. are some of the forerunners in the Biosurgery Market. Companies such as Stryker Corporation, Baxter International, Inc., Integra LifeSciences Holdings Corporation, Becton, Dickinson and Company, Medtronic PLC, and B. Braun Melsungen AG, CSL Limited, and Sanofi S.A. are some of the key innovators in Biosurgery Market. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.

Recent strategies deployed in Biosurgery Market

Partnerships, Collaborations, and Agreements:

May-2019: B. Braun Interventional Systems teamed up with NuMED Inc. and launched NuDEL™ CP Stent® Delivery System. The system has been intended for the treatment of coarctation of the aorta and right ventricular outflow tract conduit disruptions. It is the latest addition to BIS congenital and structural heart portfolio.

Product Launches and Product Expansions:

Jan-2020: Johnson and Johnson's Ethicon launched VISTASEAL Fibrin Sealant (Human) for helping the surgeons in managing bleeding during surgical procedures. VISTASEAL Fibrin Sealant (Human) includes a combination of clotting proteins, fibrinogen and thrombin that are found in human plasma.

Dec-2019: Johnson and Johnson's Ethicon introduced blood-stopping protein spray. This has been designed to quickly seal-off and control the excessive bleeding at the time of minimally invasive procedures or open surgeries. It is the first fibrin sealant, which can be used without a gas propellant.

Sep-2019: Medtronic introduced Hugo RAS system, which is a new robot-assisted surgery platform. It is the most flexible and cost-effective system.

Geographical Expansions:

Jan-2018: Sanofi expanded its project in Framingham with a two-story, 14,821-square-foot addition to its new building at the corner of New York and California avenues. The expansion is aimed at enhancing its production capacity.

Acquisition and Mergers:

Dec-2019: Baxter signed an agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The Seprafilm and Baxter's leading sealant and hemostat portfolio form a good combination altogether. The acquisition will help the company in advancing its art of healing with optimized patient care in operating room.

Nov-2019: Stryker announced an agreement to acquire Wright Medical Group N.V., a medical device company. The acquisition bolsters Stryker's global market position in extremities and trauma, providing opportunities in advance innovation, improving outcomes and reaching more patients.

Sep-2019: Integra completed the acquisition of Rebound Therapeutics, developer of single use medical devices, which enables minimally invasive access, using illumination and optics, for diagnostic, visualization, and therapeutic use. The acquisition has been helping Integra in developing innovative products for addressing the needs in neurosurgery.

Jul-2019: Integra acquired Arkis Biosciences, a company that provides a portfolio of neurosurgical devices. The acquisition strengthened Integra's position in advanced catheter technology and its offerings in neurocritical care.

May-2019: Ethicon, a subsidiary of Johnson and Johnson announced the acquisition of TachoSil Fibrin Sealant Patch from Takeda Pharmaceutical. TachoSil is a surgical patch that has been developed for enabling quick and safe bleeding control. It can be used in both adult and pediatric patients for whom standard surgical techniques such as ligature, suture, and cautery are impractical or ineffective to control bleeding.

Oct-2018: Stryker took over HyperBranch Medical Technology, a medical device manufacturer. The acquisition accelerated the growth strategy of Neurotechnology business of Stryker. The addition of Adherus to its cranial closure portfolio strengthened its position in dural repair space and helped Stryker in making healthcare better.

Jan-2018: Baxter announced an agreement to acquire Mallinckrodt's hemostat and sealant products. Through the acquisition, the company will make advancements to its sealants and hemostat and focused continually towards identifying solutions to fulfill the needs of cardiovascular and other surgical professionals.

Oct-2017: Johnson and Johnson acquired Surgical Process Institute, a specialist for digitalization and standardization of surgical workflows. The acquisition helps Johnson and Johnson in driving better patient and customer outcomes with the help of innovative technologies.

Jul-2017: Baxter acquired Claris Injectables, a subsidiary of Claris Lifesciences. The acquisition adds the new capabilities in production of essential generic Injectables medicine. It enhances the growth trajectory with high-values and essential medicines for better patient care.

Apr-2017: Becton acquired Bard, a medical technology leader in the fields of oncology, vascular, urology, and surgical specialty products. The acquisition was aimed at improving process of care and treatment of diseases for healthcare providers and patients. The portfolio of Bard increases the opportunities in fast-growing clinical areas.

Scope of the Study

Market Segmentation:

By Application

General Surgeries

Orthopedic Surgeries

Neurological Surgeries

Cardiovascular Surgeries

Other Applications

By Product

Surgical Sealants

Soft Tissue Attachments

Adhesion Barriers

Hemostatic Agents

Bone Graft Substitutes

Other Products

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

Baxter International, Inc.

Johnson and Johnson

Medtronic PLC

Pfizer, Inc.

Stryker Corporation

B. Braun Melsungen AG

Sanofi S.A.

Becton, Dickinson and Company

Integra LifeSciences Holdings Corporation

CSL Limited

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Biosurgery Market, by Application
    • 1.4.2 Global Biosurgery Market, by Product
    • 1.4.3 Global Biosurgery Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Mergers & Acquisitions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
    • 3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Dec - 2016-Apr) Leading Players

Chapter 4. Global Biosurgery Market by Application

  • 4.1 Global General Surgeries Market by Region
  • 4.2 Global Orthopedic Surgeries Market by Region
  • 4.3 Global Neurological Surgeries Market by Region
  • 4.4 Global Cardiovascular Surgeries Market by Region
  • 4.5 Global Other Application Biosurgery Market by Region

Chapter 5. Global Biosurgery Market by Product

  • 5.1 Global Surgical sealants Biosurgery Market by Region
  • 5.2 Global Soft Tissue Attachments Biosurgery Market by Region
  • 5.3 Global Adhesion Barriers Biosurgery Market by Region
  • 5.4 Global Hemostatic Agents Biosurgery Market by Region
  • 5.5 Global Bone Graft Substitutes Biosurgery Market by Region
  • 5.6 Global Others Biosurgery Market by Region

Chapter 6. Global Biosurgery Market by Region

  • 6.1 North America Biosurgery Market
    • 6.1.1 North America Biosurgery Market by Application
      • 6.1.1.1 North America General Surgeries Market by Country
      • 6.1.1.2 North America Orthopedic Surgeries Market by Country
      • 6.1.1.3 North America Neurological Surgeries Market by Country
      • 6.1.1.4 North America Cardiovascular Surgeries Market by Country
      • 6.1.1.5 North America Other Application Biosurgery Market by Country
    • 6.1.2 North America Biosurgery Market by Product
      • 6.1.2.1 North America Surgical sealants Biosurgery Market by Country
      • 6.1.2.2 North America Soft Tissue Attachments Biosurgery Market by Country
      • 6.1.2.3 North America Adhesion Barriers Biosurgery Market by Country
      • 6.1.2.4 North America Hemostatic Agents Biosurgery Market by Country
      • 6.1.2.5 North America Bone Graft Substitutes Biosurgery Market by Country
      • 6.1.2.6 North America Others Biosurgery Market by Country
    • 6.1.3 North America Biosurgery Market by Country
      • 6.1.3.1 US Biosurgery Market
        • 6.1.3.1.1 US Biosurgery Market by Application
        • 6.1.3.1.2 US Biosurgery Market by Product
      • 6.1.3.2 Canada Biosurgery Market
        • 6.1.3.2.1 Canada Biosurgery Market by Application
        • 6.1.3.2.2 Canada Biosurgery Market by Product
      • 6.1.3.3 Mexico Biosurgery Market
        • 6.1.3.3.1 Mexico Biosurgery Market by Application
        • 6.1.3.3.2 Mexico Biosurgery Market by Product
      • 6.1.3.4 Rest of North America Biosurgery Market
        • 6.1.3.4.1 Rest of North America Biosurgery Market by Application
        • 6.1.3.4.2 Rest of North America Biosurgery Market by Product
  • 6.2 Europe Biosurgery Market
    • 6.2.1 Europe Biosurgery Market by Application
      • 6.2.1.1 Europe General Surgeries Market by Country
      • 6.2.1.2 Europe Orthopedic Surgeries Market by Country
      • 6.2.1.3 Europe Neurological Surgeries Market by Country
      • 6.2.1.4 Europe Cardiovascular Surgeries Market by Country
      • 6.2.1.5 Europe Other Application Biosurgery Market by Country
    • 6.2.2 Europe Biosurgery Market by Product
      • 6.2.2.1 Europe Surgical sealants Biosurgery Market by Country
      • 6.2.2.2 Europe Soft Tissue Attachments Biosurgery Market by Country
      • 6.2.2.3 Europe Adhesion Barriers Biosurgery Market by Country
      • 6.2.2.4 Europe Hemostatic Agents Biosurgery Market by Country
      • 6.2.2.5 Europe Bone Graft Substitutes Biosurgery Market by Country
      • 6.2.2.6 Europe Others Biosurgery Market by Country
    • 6.2.3 Europe Biosurgery Market by Country
      • 6.2.3.1 Germany Biosurgery Market
        • 6.2.3.1.1 Germany Biosurgery Market by Application
        • 6.2.3.1.2 Germany Biosurgery Market by Product
      • 6.2.3.2 UK Biosurgery Market
        • 6.2.3.2.1 UK Biosurgery Market by Application
        • 6.2.3.2.2 UK Biosurgery Market by Product
      • 6.2.3.3 France Biosurgery Market
        • 6.2.3.3.1 France Biosurgery Market by Application
        • 6.2.3.3.2 France Biosurgery Market by Product
      • 6.2.3.4 Russia Biosurgery Market
        • 6.2.3.4.1 Russia Biosurgery Market by Application
        • 6.2.3.4.2 Russia Biosurgery Market by Product
      • 6.2.3.5 Spain Biosurgery Market
        • 6.2.3.5.1 Spain Biosurgery Market by Application
        • 6.2.3.5.2 Spain Biosurgery Market by Product
      • 6.2.3.6 Italy Biosurgery Market
        • 6.2.3.6.1 Italy Biosurgery Market by Application
        • 6.2.3.6.2 Italy Biosurgery Market by Product
      • 6.2.3.7 Rest of Europe Biosurgery Market
        • 6.2.3.7.1 Rest of Europe Biosurgery Market by Application
        • 6.2.3.7.2 Rest of Europe Biosurgery Market by Product
  • 6.3 Asia Pacific Biosurgery Market
    • 6.3.1 Asia Pacific Biosurgery Market by Application
      • 6.3.1.1 Asia Pacific General Surgeries Market by Country
      • 6.3.1.2 Asia Pacific Orthopedic Surgeries Market by Country
      • 6.3.1.3 Asia Pacific Neurological Surgeries Market by Country
      • 6.3.1.4 Asia Pacific Cardiovascular Surgeries Market by Country
      • 6.3.1.5 Asia Pacific Other Application Biosurgery Market by Country
    • 6.3.2 Asia Pacific Biosurgery Market by Product
      • 6.3.2.1 Asia Pacific Surgical sealants Biosurgery Market by Country
      • 6.3.2.2 Asia Pacific Soft Tissue Attachments Biosurgery Market by Country
      • 6.3.2.3 Asia Pacific Adhesion Barriers Biosurgery Market by Country
      • 6.3.2.4 Asia Pacific Hemostatic Agents Biosurgery Market by Country
      • 6.3.2.5 Asia Pacific Bone Graft Substitutes Biosurgery Market by Country
      • 6.3.2.6 Asia Pacific Others Biosurgery Market by Country
    • 6.3.3 Asia Pacific Biosurgery Market by Country
      • 6.3.3.1 China Biosurgery Market
        • 6.3.3.1.1 China Biosurgery Market by Application
        • 6.3.3.1.2 China Biosurgery Market by Product
      • 6.3.3.2 Japan Biosurgery Market
        • 6.3.3.2.1 Japan Biosurgery Market by Application
        • 6.3.3.2.2 Japan Biosurgery Market by Product
      • 6.3.3.3 India Biosurgery Market
        • 6.3.3.3.1 India Biosurgery Market by Application
        • 6.3.3.3.2 India Biosurgery Market by Product
      • 6.3.3.4 South Korea Biosurgery Market
        • 6.3.3.4.1 South Korea Biosurgery Market by Application
        • 6.3.3.4.2 South Korea Biosurgery Market by Product
      • 6.3.3.5 Singapore Biosurgery Market
        • 6.3.3.5.1 Singapore Biosurgery Market by Application
        • 6.3.3.5.2 Singapore Biosurgery Market by Product
      • 6.3.3.6 Malaysia Biosurgery Market
        • 6.3.3.6.1 Malaysia Biosurgery Market by Application
        • 6.3.3.6.2 Malaysia Biosurgery Market by Product
      • 6.3.3.7 Rest of Asia Pacific Biosurgery Market
        • 6.3.3.7.1 Rest of Asia Pacific Biosurgery Market by Application
        • 6.3.3.7.2 Rest of Asia Pacific Biosurgery Market by Product
  • 6.4 LAMEA Biosurgery Market
    • 6.4.1 LAMEA Biosurgery Market by Application
      • 6.4.1.1 LAMEA General Surgeries Market by Country
      • 6.4.1.2 LAMEA Orthopedic Surgeries Market by Country
      • 6.4.1.3 LAMEA Neurological Surgeries Market by Country
      • 6.4.1.4 LAMEA Cardiovascular Surgeries Market by Country
      • 6.4.1.5 LAMEA Other Application Biosurgery Market by Country
    • 6.4.2 LAMEA Biosurgery Market by Product
      • 6.4.2.1 LAMEA Surgical sealants Biosurgery Market by Country
      • 6.4.2.2 LAMEA Soft Tissue Attachments Biosurgery Market by Country
      • 6.4.2.3 LAMEA Adhesion Barriers Biosurgery Market by Country
      • 6.4.2.4 LAMEA Hemostatic Agents Biosurgery Market by Country
      • 6.4.2.5 LAMEA Bone Graft Substitutes Biosurgery Market by Country
      • 6.4.2.6 LAMEA Others Biosurgery Market by Country
    • 6.4.3 LAMEA Biosurgery Market by Country
      • 6.4.3.1 Brazil Biosurgery Market
        • 6.4.3.1.1 Brazil Biosurgery Market by Application
        • 6.4.3.1.2 Brazil Biosurgery Market by Product
      • 6.4.3.2 Argentina Biosurgery Market
        • 6.4.3.2.1 Argentina Biosurgery Market by Application
        • 6.4.3.2.2 Argentina Biosurgery Market by Product
      • 6.4.3.3 UAE Biosurgery Market
        • 6.4.3.3.1 UAE Biosurgery Market by Application
        • 6.4.3.3.2 UAE Biosurgery Market by Product
      • 6.4.3.4 Saudi Arabia Biosurgery Market
        • 6.4.3.4.1 Saudi Arabia Biosurgery Market by Application
        • 6.4.3.4.2 Saudi Arabia Biosurgery Market by Product
      • 6.4.3.5 South Africa Biosurgery Market
        • 6.4.3.5.1 South Africa Biosurgery Market by Application
        • 6.4.3.5.2 South Africa Biosurgery Market by Product
      • 6.4.3.6 Nigeria Biosurgery Market
        • 6.4.3.6.1 Nigeria Biosurgery Market by Application
        • 6.4.3.6.2 Nigeria Biosurgery Market by Product
      • 6.4.3.7 Rest of LAMEA Biosurgery Market
        • 6.4.3.7.1 Rest of LAMEA Biosurgery Market by Application
        • 6.4.3.7.2 Rest of LAMEA Biosurgery Market by Product

Chapter 7. Company Profiles

  • 7.1 Baxter International, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Partnerships, Collaborations, and Agreements:
      • 7.1.5.2 Acquisition and Mergers:
  • 7.2 Johnson and Johnson
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental &Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Acquisition and Mergers:
      • 7.2.5.2 Product Launches and Product Expansions:
  • 7.3 Medtronic PLC
    • 7.3.1 Company overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
  • 7.4 Pfizer, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Acquisition and Mergers:
  • 7.5 Stryker Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Acquisition and Mergers:
      • 7.5.5.2 Product Launches and Product Expansions:
  • 7.6 B. Braun Melsungen AG
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
  • 7.7 Sanofi S.A.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Geographical Expansions:
  • 7.8 Becton, Dickinson and Company
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Acquisition and Mergers:
  • 7.9 Integra LifeSciences Holdings Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Acquisition and Mergers:
  • 7.1 CSL Limited
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1. GLOBAL BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 2. GLOBAL BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 3. PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- BIOSURGERY MARKET
  • TABLE 4. PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- BIOSURGERY MARKET
  • TABLE 5. GEOGRAPHICAL EXPANSIONS- BIOSURGERY MARKET
  • TABLE 6. MERGERS & ACQUISITIONS - BIOSURGERY MARKET
  • TABLE 7. GLOBAL BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 8. GLOBAL BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 9. GLOBAL GENERAL SURGERIES MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 10. GLOBAL GENERAL SURGERIES MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 11. GLOBAL ORTHOPEDIC SURGERIES MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 12. GLOBAL ORTHOPEDIC SURGERIES MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 13. GLOBAL NEUROLOGICAL SURGERIES MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 14. GLOBAL NEUROLOGICAL SURGERIES MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 15. GLOBAL CARDIOVASCULAR SURGERIES MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 16. GLOBAL CARDIOVASCULAR SURGERIES MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 17. GLOBAL OTHER APPLICATION BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 18. GLOBAL OTHER APPLICATION BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 19. GLOBAL BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 20. GLOBAL BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 21. GLOBAL SURGICAL SEALANTS BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 22. GLOBAL SURGICAL SEALANTS BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 23. GLOBAL SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 24. GLOBAL SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 25. GLOBAL ADHESION BARRIERS BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 26. GLOBAL ADHESION BARRIERS BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 27. GLOBAL HEMOSTATIC AGENTS BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 28. GLOBAL HEMOSTATIC AGENTS BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 29. GLOBAL BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 30. GLOBAL BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 31. GLOBAL OTHERS BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 32. GLOBAL OTHERS BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 33. GLOBAL BIOSURGERY MARKET BY REGION, 2015-2018, USD MILLION
  • TABLE 34. GLOBAL BIOSURGERY MARKET BY REGION, 2019-2025, USD MILLION
  • TABLE 35. NORTH AMERICA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 36. NORTH AMERICA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 37. NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 38. NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 39. NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 40. NORTH AMERICA GENERAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 41. NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 42. NORTH AMERICA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 43. NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 44. NORTH AMERICA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 45. NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 46. NORTH AMERICA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 47. NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 48. NORTH AMERICA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 49. NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 50. NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 51. NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 52. NORTH AMERICA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 53. NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 54. NORTH AMERICA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 55. NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 56. NORTH AMERICA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 57. NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 58. NORTH AMERICA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 59. NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 60. NORTH AMERICA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 61. NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 62. NORTH AMERICA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 63. NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 64. NORTH AMERICA BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 65. US BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 66. US BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 67. US BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 68. US BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 69. US BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 70. US BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 71. CANADA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 72. CANADA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 73. CANADA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 74. CANADA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 75. CANADA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 76. CANADA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 77. MEXICO BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 78. MEXICO BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 79. MEXICO BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 80. MEXICO BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 81. MEXICO BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 82. MEXICO BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 83. REST OF NORTH AMERICA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 84. REST OF NORTH AMERICA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 85. REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 86. REST OF NORTH AMERICA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 87. REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 88. REST OF NORTH AMERICA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 89. EUROPE BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 90. EUROPE BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 91. EUROPE BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 92. EUROPE BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 93. EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 94. EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 95. EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 96. EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 97. EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 98. EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 99. EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 100. EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 101. EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 102. EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 103. EUROPE BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 104. EUROPE BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 105. EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 106. EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 107. EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 108. EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 109. EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 110. EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 111. EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 112. EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 113. EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 114. EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 115. EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 116. EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 117. EUROPE BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 118. EUROPE BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 119. GERMANY BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 120. GERMANY BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 121. GERMANY BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 122. GERMANY BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 123. GERMANY BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 124. GERMANY BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 125. UK BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 126. UK BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 127. UK BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 128. UK BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 129. UK BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 130. UK BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 131. FRANCE BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 132. FRANCE BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 133. FRANCE BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 134. FRANCE BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 135. FRANCE BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 136. FRANCE BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 137. RUSSIA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 138. RUSSIA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 139. RUSSIA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 140. RUSSIA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 141. RUSSIA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 142. RUSSIA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 143. SPAIN BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 144. SPAIN BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 145. SPAIN BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 146. SPAIN BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 147. SPAIN BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 148. SPAIN BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 149. ITALY BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 150. ITALY BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 151. ITALY BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 152. ITALY BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 153. ITALY BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 154. ITALY BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 155. REST OF EUROPE BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 156. REST OF EUROPE BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 157. REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 158. REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 159. REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 160. REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 161. ASIA PACIFIC BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 162. ASIA PACIFIC BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 163. ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 164. ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 165. ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 166. ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 167. ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 168. ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 169. ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 170. ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 171. ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 172. ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 173. ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 174. ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 175. ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 176. ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 177. ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 178. ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 179. ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 180. ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 181. ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 182. ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 183. ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 184. ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 185. ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 186. ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 187. ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 188. ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 189. ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 190. ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 191. CHINA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 192. CHINA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 193. CHINA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 194. CHINA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 195. CHINA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 196. CHINA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 197. JAPAN BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 198. JAPAN BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 199. JAPAN BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 200. JAPAN BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 201. JAPAN BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 202. JAPAN BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 203. INDIA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 204. INDIA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 205. INDIA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 206. INDIA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 207. INDIA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 208. INDIA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 209. SOUTH KOREA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 210. SOUTH KOREA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 211. SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 212. SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 213. SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 214. SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 215. SINGAPORE BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 216. SINGAPORE BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 217. SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 218. SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 219. SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 220. SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 221. MALAYSIA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 222. MALAYSIA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 223. MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 224. MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 225. MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 226. MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 227. REST OF ASIA PACIFIC BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 228. REST OF ASIA PACIFIC BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 229. REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 230. REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 231. REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 232. REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 233. LAMEA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 234. LAMEA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 235. LAMEA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 236. LAMEA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 237. LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 238. LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 239. LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 240. LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 241. LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 242. LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 243. LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 244. LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 245. LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 246. LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 247. LAMEA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 248. LAMEA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 249. LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 250. LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 251. LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 252. LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 253. LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 254. LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 255. LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 256. LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 257. LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 258. LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 259. LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 260. LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 261. LAMEA BIOSURGERY MARKET BY COUNTRY, 2015-2018, USD MILLION
  • TABLE 262. LAMEA BIOSURGERY MARKET BY COUNTRY, 2019-2025, USD MILLION
  • TABLE 263. BRAZIL BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 264. BRAZIL BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 265. BRAZIL BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 266. BRAZIL BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 267. BRAZIL BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 268. BRAZIL BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 269. ARGENTINA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 270. ARGENTINA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 271. ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 272. ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 273. ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 274. ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 275. UAE BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 276. UAE BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 277. UAE BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 278. UAE BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 279. UAE BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 280. UAE BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 281. SAUDI ARABIA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 282. SAUDI ARABIA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 283. SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 284. SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 285. SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 286. SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 287. SOUTH AFRICA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 288. SOUTH AFRICA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 289. SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 290. SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 291. SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 292. SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 293. NIGERIA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 294. NIGERIA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 295. NIGERIA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 296. NIGERIA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 297. NIGERIA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 298. NIGERIA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 299. REST OF LAMEA BIOSURGERY MARKET, 2015-2018, USD MILLION
  • TABLE 300. REST OF LAMEA BIOSURGERY MARKET, 2019-2025, USD MILLION
  • TABLE 301. REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2015-2018, USD MILLION
  • TABLE 302. REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2019-2025, USD MILLION
  • TABLE 303. REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2015-2018, USD MILLION
  • TABLE 304. REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2019-2025, USD MILLION
  • TABLE 305. KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 306. KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 307. KEY INFORMATION - MEDTRONIC PLC
  • TABLE 308. KEY INFORMATION - PFIZER, INC.
  • TABLE 309. KEY INFORMATION - STRYKER CORPORATION
  • TABLE 310. KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 311. KEY INFORMATION - SANOFI S.A.
  • TABLE 312. KEY INFORMATION - BECTON, DICKINSON AND COMPANY
  • TABLE 313. KEY INFORMATION - INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • TABLE 314. KEY INFORMATION - CSL LIMITED

LIST OF FIGURES

  • FIG 1. METHODOLOGY FOR THE RESEARCH
  • FIG 2. KBV CARDINAL MATRIX
  • FIG 3. KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
  • FIG 4. KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS : 2019-DEC - 2016-APR) LEADING PLAYERS
  • FIG 5. RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.